SAT1 Overexpression Eases Alpha-Synuclein Toxicity in Fly Model of Parkinson’s Disease

A polyamine-clearing enzyme may blunt some of the molecular damage caused by alpha-synuclein, the protein whose accumulation defines Parkinson’s disease pathology. In a study published in the journal Amino Acids, researchers report that overexpressing spermidine/spermine N¹-acetyltransferase 1, or SAT1, in the neurons of fruit flies reduced alpha-synuclein protein levels, altered the protein’s distribution within the brain, and extended the shortened lifespan of flies engineered to produce the human protein in their neurons. The work, led by Zoya R. Bangash and Wei-Ling Tsou of Wayne State University together with colleagues including Peter A. LeWitt and Sokol V. Todi, builds on transcriptomic, imaging, and biochemical evidence gathered in Drosophila, an in vivo model widely used to study synuclein toxicity.

The team used the elav-Gal4 driver to express human alpha-synuclein pan-neuronally, with or without a co-expressed SAT1 transgene. Western blotting of fly heads showed that SAT1 co-expression significantly lowered alpha-synuclein protein abundance compared with alpha-synuclein expression alone. Quantitative reverse-transcription PCR indicated that SAT1 did not reduce the abundance of alpha-synuclein messenger RNA, pointing to a post-transcriptional mechanism rather than suppressed transgene activity. Immunostaining of the female fly brain added a spatial dimension: in flies expressing alpha-synuclein alone, the protein’s signal was concentrated in neuronal cell bodies with pronounced perinuclear enrichment, whereas SAT1 co-expression produced a broader, more diffuse signal with fewer perinuclear accumulations.

Lifespan assays reinforced the protective picture, though with important caveats. Pan-neuronal alpha-synuclein expression drastically shortened survival in both sexes. SAT1 co-expression significantly extended survival in alpha-synuclein-expressing flies of both sexes, but the rescue was strongly sex-biased: females gained far more lifespan than males. Notably, SAT1 overexpression on its own caused a marginal reduction in baseline lifespan, particularly in males, suggesting that pushing polyamine catabolism carries a modest physiological cost when no proteotoxic stress is present. The authors emphasize that the benefit is context dependent, outweighing its costs only under alpha-synuclein-induced stress.

To understand what SAT1 changes at the level of gene expression, the researchers performed RNA sequencing on fly heads from four genotypes: control, SAT1 alone, alpha-synuclein alone, and both together, with five biological replicates per group and 70 heads per replicate. Differential expression analysis using DESeq2 identified substantial sets of genes with adjusted p-values below 0.05 and absolute log₂ fold changes greater than 1 in each of three contrasts. Principal component analysis separated samples cleanly by genotype, with the first principal component accounting for 51 percent of variance and the second for 20 percent. Control and SAT1-alone samples clustered closely, indicating minimal transcriptional perturbation from SAT1 overexpression in the absence of alpha-synuclein, while alpha-synuclein shifted the transcriptome in a distinct direction and SAT1 co-expression formed yet another separate cluster.

That clustering pattern carries a key conceptual message: SAT1 does not simply push the alpha-synuclein transcriptome back toward baseline. A reversal analysis integrating the alpha-synuclein-versus-control and co-expression-versus-alpha-synuclein comparisons showed reciprocal regulation for specific genes, indicating selective counter-regulation rather than global restoration. Among the genes upregulated by alpha-synuclein and dampened by SAT1 were the stress-inducible chaperone HSP70Bb, the constitutive chaperone HSC70-2, the ubiquitin hydrolase Uch-L5R, the lipid transporter ABCA3, and the glucose and fructose transporter SLC2A8. Expression of phr, a DNA photolyase, rose with both SAT1 and alpha-synuclein and showed additive effects under co-expression.

Mitochondrial quality-control genes figured prominently in this counter-regulated set. Alpha-synuclein expression altered transcripts encoding CHDH, a mitochondrial enzyme involved in osmoprotection and metabolism; USP30, a deubiquitinase that negatively regulates mitophagy; TCAIM, a regulator of mitochondrial stress responses; RNF185, an E3 ubiquitin ligase implicated in mitochondrial surveillance; and SLC25A15, the mitochondrial ornithine carrier that links urea-cycle and amino acid metabolism to polyamine biosynthesis. SAT1 co-expression partially restored alpha-synuclein-associated changes in these genes, including recovery of SLC25A15 expression. Functional enrichment analyses likewise showed that alpha-synuclein suppressed pathways tied to mitochondrial ornithine transport, a step the authors argue could uncouple mitochondrial metabolism from cellular control of polyamine balance.

Biochemical fractionation of fly heads lent physical support to the transcriptomic signals. Using the mitochondrial marker ATP5A and the autophagy marker LC3, the researchers found that alpha-synuclein-expressing neurons showed reduced ATP5A signal and sparse LC3 puncta, while SAT1 co-expression was associated with stronger ATP5A intensity, more abundant LC3 puncta, and greater spatial overlap between the two markers in the neuropil. In isolated mitochondrial fractions, alpha-synuclein levels were lower when SAT1 was present, and the phosphorylated Ser129 form of alpha-synuclein, a species associated with pathological aggregation, was reduced even more markedly, lowering the pS129-to-total alpha-synuclein ratio. LC3-II levels, which declined with alpha-synuclein expression, partially recovered with SAT1, raising the LC3-II/LC3-I ratio, while K63-linked ubiquitin levels did not differ significantly across conditions. SAT1 protein itself was detected mainly in cytosolic and pellet fractions, not enriched in mitochondria.

Functional measurements of cellular energy homeostasis aligned with these observations. A luciferase-based assay of steady-state ATP in adult fly heads showed that SAT1 overexpression alone significantly increased ATP content in both sexes, while alpha-synuclein expression significantly depleted it. SAT1 co-expression significantly attenuated the alpha-synuclein-induced ATP deficit, with p-values below 0.01 in males and below 0.001 in females. In males, ATP levels were restored to values comparable to controls; in females they exceeded control levels, mirroring the greater lifespan extension seen in females. The authors caution that ATP content alone cannot distinguish altered production from altered consumption, and that measurements of mitochondrial respiration and membrane potential will be needed to pin down the bioenergetic mechanism.

The study’s lineage matters for interpreting its claims. It extends the group’s earlier work, in which neuronal SAT1 knockdown worsened alpha-synuclein pathology while overexpression protected against it, and it is consistent with mammalian findings in which pharmacologic SAT1 inhibition with berenil elevated spermidine and spermine and exacerbated alpha-synuclein aggregation in transgenic mice, whereas SAT1 activation reduced alpha-synuclein accumulation. Human postmortem analyses have reported reduced SAT1 expression in Parkinson’s-vulnerable brainstem regions such as the dorsal motor nucleus of the vagus relative to more resistant regions. Context also cuts both ways: spermidine and spermine can accelerate alpha-synuclein fibril formation in vitro, yet spermidine is also a well-established inducer of autophagy, making the outcome of polyamine flux dependent on how it is regulated.

The authors are careful about scope. The findings establish robust associations among SAT1 expression, reduced alpha-synuclein toxicity, transcriptional modulation, and mitochondrial and autophagy-linked signatures in flies, but they do not establish causality, and the pan-neuronal expression system does not address cell-type-specific effects, leaving dopaminergic neuron-specific models as a necessary next step. The sex-dependent mechanisms behind the dimorphic rescue also remain undefined, as the study was not designed to test them. Within those limits, the work positions polyamine interconversion at an intersection of mitochondrial amino acid transport, stress regulation, and neuronal resilience under alpha-synuclein stress, and identifies SAT1 as a functionally relevant regulator of neuronal stress adaptation in a synucleinopathy model.

Subject of Research: The role of the polyamine metabolism enzyme SAT1 in modulating alpha-synuclein toxicity and mitochondrial homeostasis in a Drosophila model of Parkinson's disease.

Article Title: Polyamine metabolic enzyme SAT1 remodels the neuronal transcriptome and rescues α-synuclein toxicity in Drosophila

Article References: Bangash, Z. R., Matsui, H., Ranxhi, B., Todi, S. V., LeWitt, P. A., & Tsou, W.-L. (2026). Polyamine metabolic enzyme SAT1 remodels the neuronal transcriptome and rescues α-synuclein toxicity in Drosophila. Amino Acids, 58(1), Article 48. https://doi.org/10.1007/s00726-026-03544-y

Image Credits: AI Generated

DOI: 10.1007/s00726-026-03544-y

Keywords: SAT1, polyamine metabolism, alpha-synuclein, Parkinson's disease, Drosophila, mitochondria, transcriptomics, autophagy, LC3, ATP, neurodegeneration, SLC25A15